PrEP, or pre-exposure prophylaxis, is a preventive medication for individuals who do not have HIV but are at high risk of contracting the virus. The primary purpose of PrEP is to significantly reduce the risk of HIV infection when taken consistently as prescribed. The medication contains two antiretroviral drugs, tenofovir and emtricitabine, which work by blocking the virus’s ability to replicate in the body.

When taken daily, PrEP can reduce the risk of getting HIV from sex by over 99% and from injection drug use by about 74%. It is crucial for those considering PrEP to undergo regular HIV testing and have their kidney function monitored, as these steps are vital for ensuring the treatment is safe and effective. Additionally, it is recommended to engage in regular follow-ups with a healthcare provider, typically every three months, to reassess ongoing risk factors, conduct testing, and address any concerns.

PrEP is not a standalone solution; it should be part of a broader strategy for preventing HIV transmission. Combining PrEP with other safer sex practices, such as using condoms and having open discussions about sexual health with partners, can enhance its effectiveness. For individuals who are at high risk of HIV, PrEP offers a powerful tool that empowers them to take control of their sexual health.

If you believe you may be at risk for HIV, consult with a healthcare professional to determine if PrEP is right for you. They can provide you with information on how to access PrEP, potential side effects, and what to expect throughout your treatment journey.